Colleen Lowe, DPM
Podiatrist · Waterloo, IANPI 1215506191
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,708 of the $4,741 with a category attached, or 78.2%. Stryker accounts for 65.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $2,836 and has fallen 82.9% since, to $485 in 2025.
Across 92 payments — averaging $51.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Convatec Inc.$282
- AbbVie$215
- Johnson & Johnson$194
- Organogenesis Inc.$183
- Treace Medical Concepts, Inc.$177
- plus $601 from 12 others
What the payments were for
- Travel & lodging$1,03222%
- Food & beverage$3,70878%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 54 | $3,089 |
| Convatec Inc. | 7 | $282 |
| AbbVie | 4 | $215 |
| Johnson & Johnson | 4 | $194 |
| Organogenesis Inc. | 3 | $183 |
| Treace Medical Concepts, Inc. | 2 | $177 |
| Smith+Nephew | 4 | $149 |
| DJO, LLC | 1 | $93 |
| Prism Medical | 2 | $77 |
| Wardlow Enterprises | 2 | $71 |
| Bioventus LLC | 1 | $61 |
| Zimmer Biomet | 1 | $46 |
| Orthofix Medical, Inc. | 2 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Vertex | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $14 |
| Recordati_rare_diseases_inc. | 1 | $13 |
| Kerecis Limited | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ORTHOLOC 3DI$1,161
- AUGMENT INJECTABLE$175
- PROSTEP MICA$163
- ORTHOLOC 2 LAPIFUSE$145
- InnovaMatrix AC$144
- CITREFIX$143
- PuraPly$113
- Lapiplasty System$101
How this compares
$4,741 in reported general payments places this provider in the 75th percentile of 94 podiatrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 15 | $177 |
| SsdSilver Sulfadiazine | 15 | $87 |
| Meloxicam | 15 | $67 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Waterloo
- Travis TidwellWaterloo$33K
- Ronald KaneWaterloo$11K
- Stephen MeyerWaterloo$3K
- Levi AndrewsWaterloo$755
- Paul DaytonAnkeny$9.4M
- Mindi DaytonAnkeny$333K
- Eric BarpWest Des Moines$149K
- Eric TempleWest Des Moines$19K
- Eric JensenCarroll$17K
- Eric ReeseWest Des Moines$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.